Professor Gerald V Stimson

Publications


Journals

  • Aceijas C; Oppenheimer E; Stimson GV; Ashcroft RE; Matic S; Hickman M. (1 Sep 2006). Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the 'Treating 3 million by 2005. Making it happen. The WHO strategy' ('3by5'). ADDICTION. 101:1246-1253. Author weblink DOI.
  • Dolan K; Kite B; Black E; Aceijas C; Stimson GV. (1 Jan 2007). HIV in prison in low-income and middle-income countries. LANCET INFECTIOUS DISEASES. 7:32-41. Author weblink DOI.
  • Metrebian N; Mott J; Carnwath Z; Carnwath T; Stimson GV; Sell L. (1 Jan 2007). Pathways into receiving a prescription for diamorphine (heroin) for the treatment of opiate dependence in the United Kingdom. EUROPEAN ADDICTION RESEARCH. 13:144-147. Author weblink DOI.
  • Hickman M; Madden P; Henry J; Baker A; Wallace C; Wakefield J; Stimson G; Elliott P. (2003). Trends in drug overdose deaths in England and Wales 1993-98: methadone does not kill more people than heroin. Addiction. 98:419-425.
  • Hickman M; Carnwath Z; Madden P; Farrell M; Rooney C; Ashcroft R; Judd A; Stimson G. (2003). Drug related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London. Journal of Urban Studies. 2, 80:274-287.
  • Hickman M; Griffin M; Madden P; Sondhi A; Corkery J; Mott J; Stimson G V. (2003). Continuing the epidemiological function of the Addicts Index - evidence from matching the Home Office Addicts Index with the National Drug Treatment Monitoring System. Drugs, Education, Prevention and Policy. 2, 11:91-100.
  • Weaver T; Hickman M; Rutter D; Ward J; Stimson G; Renton A. (2001). The prevalence and management of co-morbid substance misuse and mental illness: results of a screening survey in substance misuse and mental health treatment populations. Drug Alcohol Rev. 20, 3:407-416.
  • Stimson GV; Donoghoe MC; Fitch C. (2001). Rapid Assessment and Response Technical Guide (TG-RAR) Version 1.0. World Health Organization.
  • Des Jarlais DC; Perlis TE; Stimson GV; Poznyak V. (2 Mar 2006). Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II. BMC PUBLIC HEALTH. 6. Author weblink DOI.
  • Dolan KA; Donoghoe MC; Stimson GV. (1993). Reductions in HIV risk behaviour and stable HIV prevalence in syringe-exchange clients and other injectors in England. Drug Alcohol Rev. 12:133-142. DOI.
  • Metrebian N; Stimson GV; Shanahan W; Alcorn R; Sell L; Nunn A; Gabe R; Knapp M; et alByford S; Epstein D; Thompson S; Medhikhani M; Harley D; Medjesi-Jones M; Campbell G; Carnwath T; Ruben S. (1 Dec 2005). Pilot UK-injectable methadone trial (pilot UK-INJECT). DRUGS-EDUCATION PREVENTION AND POLICY. 12:111-114. Author weblink.
  • Metrebian N; Carnwath Z; Mott J; Carnwath T; Stimson GV; Sell L. (Mar 2006). Patients receiving a prescription for diamorphine (heroin) in the United Kingdom. Drug Alcohol Rev. 25:115-121. DOI.
  • Stimson GV; Fitch C; DesJarlais D; Poznyak V; Perlis T; Oppenheimer E; Rhodes T. (Feb 2006). Rapid assessment and response studies of injection drug use: knowledge gain, capacity building, and intervention development in a multisite study. Am J Public Health. 96:288-295. DOI.
  • Stimson GV; Hickman M; Rhodes T; Bastos F; Saidel T. (1 Dec 2005). Methods for assessing HIV and HIV risk among IDUs and for evaluating interventions. INTERNATIONAL JOURNAL OF DRUG POLICY. 16:S7-S20. Author weblink DOI.
  • STIMSON GV. (1 Mar 1990). AIDS AND HIV - THE CHALLENGE FOR BRITISH DRUG SERVICES. BRITISH JOURNAL OF ADDICTION. 85:329-339. Author weblink.
  • LART R; STIMSON GV. (1 Nov 1990). NATIONAL SURVEY OF SYRINGE EXCHANGE SCHEMES IN ENGLAND. BRITISH JOURNAL OF ADDICTION. 85:1433-1443. Author weblink.
  • PICKERING H; STIMSON GV. (4 Sep 1993). SYRINGE SHARING IN PRISON. LANCET. 342:621-622. Author weblink DOI.
  • RHODES TJ; BLOOR MJ; DONOGHOE MC; HAW S; ETTORE B; PLATT S; FRISCHER M; HUNTER GM; et alTAYLOR A; FINLAY A; CROSIER AN; STEPHENS S; COVELL R; STIMSON GV; GOLDBERG DJ; GREEN ST; MCKEGANEY NP; PARRY J. (1 Jan 1993). HIV PREVALENCE AND HIV RISK BEHAVIOR AMONG INJECTING DRUG-USERS IN LONDON AND GLASGOW. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV. 5:413-425. Author weblink DOI.
  • RHODES T; STIMSON GV. (1 Mar 1994). WHAT IS THE RELATIONSHIP BETWEEN DRUG TAKING AND SEXUAL RISK - SOCIAL-RELATIONS AND SOCIAL-RESEARCH. SOCIOLOGY OF HEALTH & ILLNESS. 16:209-228. Author weblink DOI.
  • TURNBULL P; STIMSON GV. (25 Jun 1994). DRUG-USE IN PRISON. BRITISH MEDICAL JOURNAL. 308:1716-1716. Author weblink.
  • STIMSON GV. (1 Nov 1994). RECONSTRUCTION OF SUBREGIONAL DIFFUSION OF HIV-INFECTION AMONG INJECTING DRUG-USERS IN SOUTHEAST-ASIA - IMPLICATIONS FOR EARLY INTERVENTION. AIDS. 8:1630-1632. Author weblink DOI.
  • GREEN A; PICKERING H; FOSTER R; POWER R; STIMSON GV. (1 Jan 1994). WHO USES COCAINE - SOCIAL PROFILES OF COCAINE USERS. ADDICTION RESEARCH. 2:141-154. Author weblink DOI.
  • STIMSON GV; RHODES T; POWER R; EATON G. (1 Oct 1995). CAN OUTREACH WORK - REPLY. ADDICTION. 90:1402-1404. Author weblink DOI.
  • Rhodes T; Stimson GV; Quirk A. (1 Jan 1996). Sex, drugs, intervention, and research: From the individual to the social. SUBSTANCE USE & MISUSE. 31:375-407. Author weblink DOI.
  • Stimson GV. (1 Aug 1996). Has the United Kingdom averted an epidemic of HIV-1 infection among drug injectors?. ADDICTION. 91:1085-1088. Author weblink.
  • Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C. (1 Oct 1996). Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: Injecting careers, positivity and risk behaviour. ADDICTION. 91:1457-1467. Author weblink DOI.
  • Adelekan ML; Stimson GV. (1 Dec 1997). Problems and prospects of implementing harm reduction for HIV and injecting drug use in high risk sub-Saharan African countries. JOURNAL OF DRUG ISSUES. 27:97-116. Author weblink.
  • Stimson GV; Rhodes T. (1 Jun 1997). Conditions for the successful implementation of harm reduction. DRUG AND ALCOHOL REVIEW. 16:178-180. Author weblink.
  • Hickman M; Sutcliffe H; Sondhi A; Stimson GV. (6 Sep 1997). Validation of a regional drug misuse database: implications for policy and surveillance of problem drug use in the UK. BRITISH MEDICAL JOURNAL. 315:581-581. Author weblink.
  • Stimson GV; Hickman M; Turnbull PJ. (14 Nov 1998). Statistics on misuse of drugs have been misused. BRITISH MEDICAL JOURNAL. 317:1388-1388. Author weblink.
  • Burrows D; Rhodes T; Trautmann F; Bijl M; Stimson GV; Sarankov Y; Ball A; Fitch C. (1 Dec 1998). Responding to HIV infection associated with drug injecting in Eastern Europe. DRUG AND ALCOHOL REVIEW. 17:453-463. Author weblink DOI.
  • Stimson GV; Fitch C; Rhodes T; Ball A. (1 Sep 1999). Rapid assessment and response: methods for developing public health responses to drug problems. DRUG AND ALCOHOL REVIEW. 18:317-325. Author weblink.
  • Lilly R; Quirk A; Rhodes T; Stimson GV. (1 Jan 1999). Juggling multiple roles: Staff and client perceptions of keyworker roles and the constraints on delivering counselling and support services in methadone treatment. ADDICTION RESEARCH. 7:267-289. Author weblink DOI.
  • Judd A; Stimson GV; Hickman M; Macleod J. (19 Feb 2000). Accuracy of perceptions of hepatitis B and C status - Results require further clarification. BRITISH MEDICAL JOURNAL. 320:512-513. Author weblink.
  • Lilly R; Quirk A; Rhodes T; Stimson GV. (1 May 2000). Sociality in Methadone Treatment: understanding methadone treatment and service delivery as a social process. DRUGS-EDUCATION PREVENTION AND POLICY. 7:163-178. Author weblink DOI.
  • Metrebian N; Stimson GV. (1 Jan 2000). Heroin prescribing in the UK: Lost opportunities for research. ADDICTION RESEARCH. 8:305-310. Author weblink DOI.
  • Judd A; Hickman M; Stimson GV; Hope VD; Gill O; Parry JV. (1 Apr 2001). Epidemiology of hepatitis C virus in injecting drug users in England and Wales: Implications for HCV drug therapy. JOURNAL OF HEPATOLOGY. 34:127-127. Author weblink DOI.
  • Metrebian N; Shanahan W; Stimson GV; Small C; Lee M; Mtutu V; Wells B. (1 Sep 2001). Prescribing drug of choice to opiate dependent drug users: a comparison of clients receiving heroin with those receiving injectable methadone at a West London drug clinic. DRUG AND ALCOHOL REVIEW. 20:267-276. Author weblink.
  • Fitch C; Stimson GV; Jones S; Hickman M; Muscat I; Gafoor M. (1 Aug 2003). Responding to drug use in Jersey: findings and outcomes from a multimethod rapid assessment. DRUGS-EDUCATION PREVENTION AND POLICY. 10:223-234. Author weblink DOI.
  • Hope VD; Judd A; Hickman M; Sutton A; Stimson GV; Parry JV; Gill ON. (22 Jul 2005). HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years. AIDS. 19:1207-1214. Author weblink DOI.
  • Power R; Stimson GV; Strang J. (1990). Drug prevention and HIV policy. AIDS. 4 Suppl 1:S263-S267.
  • Stimson GV. (Mar 1990). The fourth Okey memorial lecture. AIDS and HIV: the challenge for British drug services. Br J Addict. 85:329-339.
  • Stimson GV; Lart R. (Dec 1991). HIV, drugs, and public health in England: new worlds, old tunes. Int J Addict. 26:1263-1277.
  • Turnbull PJ; Stimson GV; Dolan KA. (11 Jan 1992). Prevalence of HIV infection among ex-prisoners in England. BMJ. 304:90-91.
  • Stimson GV; Power R. (Mar 1992). Assessing AIDS prevention for injecting drug users; some methodological considerations. Br J Addict. 87:455-465.
  • Donoghoe MC; Dolan KA; Stimson GV. (Jul 1992). Life-style factors and social circumstances of syringe sharing in injecting drug users. Br J Addict. 87:993-1003.
  • Stimson GV. (1993). The global diffusion of injecting drug use: implications for human immunodeficiency virus infection. Bull Narc. 45:3-17.
  • Turnbull PJ; Dolan KA; Stimson GV. (1993). HIV testing, and the care and treatment of HIV positive people in English prisons. AIDS Care. 5:199-206. DOI.
  • Donoghoe MC; Rhodes TJ; Hunter GM; Stimson GV. (Aug 1993). HIV testing and unreported HIV positivity among injecting drug users in London. AIDS. 7:1105-1111.
  • Keene J; Stimson GV; Jones S; Parry-Langdon N. (Aug 1993). Evaluation of syringe-exchange for HIV prevention among injecting drug users in rural and urban areas of Wales. Addiction. 88:1063-1070.
  • Rhodes TJ; Donoghoe MC; Hunter GM; Stimson GV. (Nov 1993). Continued risk behaviour among HIV positive drug injectors in London: implications for intervention. Addiction. 88:1553-1560.
  • Rhodes T; Donoghoe M; Hunter G; Stimson GV. (1994). HIV prevalence no higher among female drug injectors also involved in prostitution. AIDS Care. 6:269-276. DOI.
  • Rhodes T; Donoghoe M; Hunter G; Soteri A; Stimson GV. (Sep 1994). Sexual behaviour of drug injectors in London: implications for HIV transmission and HIV prevention. Addiction. 89:1085-1096.
  • Pickering H; Stimson GV. (Nov 1994). Prevalence and demographic factors of stimulant use. Addiction. 89:1385-1389.
  • Stimson GV; Eaton G; Rhodes T; Power R. (Dec 1994). Potential development of community oriented HIV outreach among drug injectors in the UK. Addiction. 89:1601-1611.
  • Hunter GM; Donoghoe MC; Stimson GV; Rhodes T; Chalmers CP. (May 1995). Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993. AIDS. 9:493-501.
  • Stimson GV. (Sep 1995). AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic. Soc Sci Med. 41:699-716.
  • Hunter GM; Donoghoe MC; Stimson GV. (Oct 1995). Crack use and injection on the increase among injecting drug users in London. Addiction. 90:1397-1400.
  • Stimson GV; Hunter G. (1996). Interventions with drug injectors in the UK: trends in risk behaviour and HIV prevalence. Int J STD AIDS. 7 Suppl 2:52-56.
  • Adelekan M; Metrebian N; Tallack F; Stimson GV; Shanahan W. (Mar 1996). Who should collect Opiate Treatment Index data in opiate treatment outcome monitoring: clinic staff or researchers?. Drug Alcohol Rev. 15:65-71. DOI.
  • Stimson GV; Hunter GM; Donoghoe MC; Rhodes T; Parry JV; Chalmers CP. (Jun 1996). HIV-1 prevalence in community-wide samples of injecting drug users in London, 1990-1993. AIDS. 10:657-666.
  • Turnbull PJ; Power R; Stimson GV. (Sep 1996). "Just using old works": injecting risk behaviour in prison. Drug Alcohol Rev. 15:251-260. DOI.
  • Quirk A; Rhodes T; Stimson GV. (Feb 1998). 'Unsafe protected sex': qualitative insights on measures of sexual risk. AIDS Care. 10:105-114. DOI.
  • Metrebian N; Shanahan W; Wells B; Stimson GV. (15 Jun 1998). Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions. Med J Aust. 168:596-600.
  • Stimson GV; Jones S; Chalmers C; Sullivan D. (Mar 1998). A short questionnaire (IRQ) to assess injecting risk behaviour. Addiction. 93:337-347.
  • Judd A; Hunter GM; Maconochie N; Hickman M; Parry JV; Renton AM; Stimson GV. (7 May 1999). HIV prevalence and risk behaviour among female injecting drug users in London, 1990 to 1996. AIDS. 13:833-837.
  • Rhodes T; Stimson GV; Fitch C; Ball A; Renton A. (3 Jul 1999). Rapid assessment, injecting drug use, and public health. Lancet. 354:65-68. DOI.
  • Hickman M; Sutcliffe H; Sondhi A; Stimson GV. (Sep 1999). Surveillance of problem drug use in the UK: a review of a Regional Drug Misuse Database. J Public Health Med. 21:271-277.
  • Rhodes T; Ball A; Stimson GV; Kobyshcha Y; Fitch C; Pokrovsky V; Bezruchenko-Novachuk M; Burrows D; et alRenton A; Andrushchak L. (Sep 1999). HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics. Addiction. 94:1323-1336.
  • Fitch C; Rhodes T; Stimson GV. (1 Mar 2000). Origins of an epidemic: the methodological and political emergence of rapid assessment. Int J Drug Policy. 11:63-82.
  • Rhodes T; Stimson GV; Crofts N; Ball A; Dehne K; Khodakevich L. (1999). Drug injecting, rapid HIV spread, and the 'risk environment': implications for assessment and response. AIDS. 13 Suppl A:S259-S269.
  • Stimson GV. (Aug 2000). 'Blair declares war' : the unhealthy state of British drug policy. Int J Drug Policy. 11:259-264.
  • Fitch C; Stimson GV; Rhodes T; Poznyak V. (Nov 2004). Rapid assessment: an international review of diffusion, practice and outcomes in the substance use field. Soc Sci Med. 59:1819-1830. DOI.
  • Judd A; Hickman M; Jones S; McDonald T; Parry JV; Stimson GV; Hall AJ. (1 Jan 2005). Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ. 330:24-25. DOI.
  • Aceijas C; Stimson GV; Hickman M; Rhodes T; United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries. (19 Nov 2004). Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 18:2295-2303.
  • Alkhawari FS; Stimson GV; Warrens AN. (Jun 2005). Attitudes toward transplantation in U.K. Muslim Indo-Asians in west London. Am J Transplant. 5:1326-1331. DOI.
  • Judd A; Hutchinson S; Wadd S; Hickman M; Taylor A; Jones S; Parry JV; Cameron S; et alRhodes T; Ahmed S; Bird S; Fox R; Renton A; Stimson GV; Goldberg D. (Nov 2005). Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis. J Viral Hepat. 12:655-662. DOI.
  • Hunter GM; Stimson GV; Judd A; Jones S; Hickman M. (Sep 2000). Measuring injecting risk behaviour in the second decade of harm reduction: a survey of injecting drug users in England. Addiction. 95:1351-1361.
  • Judd A; Stimson GV; Hickman M; Hunter GM; Jones S; Parry JV; Madden P. (20 Oct 2000). Prevalence of HIV infection in a multi-site sample of injecting drug users not in contact with treatment services in England. AIDS. 14:2413-2415.
  • Hope VD; Judd A; Hickman M; Lamagni T; Hunter G; Stimson GV; Jones S; Donovan L; et alParry JV; Gill ON. (Jan 2001). Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?. Am J Public Health. 91:38-42.
  • Stimson GV; Rhodes T. (1 Apr 2001). Promoting rational drug policy. Int J Drug Policy. 12:1-2.
  • Weaver T; Rutter D; Madden P; Ward J; Stimson G; Renton A. (Aug 2001). Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: prevalence and service needs in an inner London borough. Soc Psychiatry Psychiatr Epidemiol. 36:399-406.
  • Parsons J; Hickman M; Turnbull PJ; McSweeney T; Stimson GV; Judd A; Roberts K. (Jul 2002). Over a decade of syringe exchange: results from 1997 UK survey. Addiction. 97:845-850.
  • Metrebian N; Carnwath T; Stimson GV; Storz T. (Sep 2002). Survey of doctors prescribing diamorphine (heroin) to opiate-dependent drug users in the United Kingdom. Addiction. 97:1155-1161.

Books

  • Borrill J; Maden A; Martin A; Weaver T; Stimson G; Farrell M; Barnes T; Burnett R; et alBriggs D. The substance misuse treatment needs of minority prisoner groups: women, young offenders and ethnic minorities. Home Office Development & Practice Report 8., London: Home Office RDS.
  • Fitch C; Stimson GV. RAR Review: an international review of rapid assessments conducted on drug use. Geneva, World Health Organization (2003).
  • Stimson GV. Prescribing Heroin: What is the evidence?. Joseph Rowntree Foundation, York Publishing Services Ltd (2003).

Conferences

  • Stimson GV; Hunter G. Interventions with drug injectors in the UK: Trends in risk behaviour and HIV prevalence. Conference on HIV Behavioural Interventions. 7:52-56. (Feb 1996).
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook